Reddon H, Grant C, Nosova E, Fairbairn N, Barrios R, Justice A, Nolan S, Socías ME, Milloy MJ The Veterans Aging Cohort Study (VACS) Index predicts mortality in a community-recruited cohort of HIV-positive people who use illicit drugs Clin Infect Dis PubMed

Brar R, Fairbairn N, Colizza K, Ryan A, Nolan S Hospital initiated injectable opioid agonist therapy for the treatment of severe opioid use disorder: a case series J Addict Med PubMed

Liang J, Nosova E, Reddon H, Nolan S, Socías ME, Barrios R, Milloy MJ Longitudinal patterns of illicit drug use, ART exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs AIDS PubMed

Braithwaite V, Fairgrieve C, Nolan S Sustained-release oral hydromorphone for the treatment of opioid use disorder J Addict Med PubMed

Brar R, Fairbairn N, Sutherland C, Nolan S Use of a novel prescribing approach for the treatment of opioid use disorder: buprenorphine/naloxone micro-dosing - a case series Drug Alcohol Rev PubMed

Ronsley C, Nolan S, Knight R, Hayashi K, Klimas J, Walley A, Wood E, Fairbairn N Treatment of stimulant use disorder: a systematic review of reviews PLoS One PubMed

Socías ME, Nolan S Can extended-release injectable medications help curb United States and Canada's opioid overdose epidemic? J Addict Med PubMed

Ickowicz S, Dong H, Ti L, Nolan S, Fairbairn N, Barrios R, Milloy MJ Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017 AIDS Care PubMed

Caulfield MDG, Brar R, Sutherland C, Nolan S Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach BMJ Case Rep PubMed

Ickowicz S, Brar R, Nolan S Case study: naltrexone for the treatment of nitrous oxide use J Addict Med PubMed